Quinazolinone-type compounds as CRTH2 antagonists

This application provides for compounds of the formula or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KELLEY, ELIZABETH HELEN, HUANG, XIAN-HAI, YU, YOU-NONG, SILIPHAIVANH, PHIENG, ZHOU, WEI, MAZZOLA, ROBERT D. JR, ZHANG, HONG-JUN, MCCORMICK, KEVIN D, QIN, JUN, CALDWELL, JOHN P, BIJU, PURAKKATTLE JOHNY, LEYHANE, ANDREW J, TANG, HAI-QUN, DONG, LI, METHOT, JOEY L, XIAO, DONG, GAUUAN, JOLICIA POLIVINA, PALANI, ANANDAN, MACCOSS, RACHEL N, ASLANIAN, ROBERT G, DHONDI, PAWAN K, BOYCE, CHRISTOPHER W, MCKITTRICK, BRIAN A, SHAO, NING, JIANG, QIN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This application provides for compounds of the formula or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTH2 receptor.